Maraoui Claude 4
4 · Journey Medical Corp · Filed Apr 16, 2025
Insider Transaction Report
Form 4
Maraoui Claude
DirectorPresident & CEO
Transactions
- Award
Common Stock, $0.0001 par value
2024-01-03+175,000→ 2,178,147 total - Award
Common Stock, $0.0001 par value
2024-05-01+175,000→ 2,353,147 total
Footnotes (3)
- [F1]On January 3, 2024, the reporting person was granted 175,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that vested or will vest in accordance with the following schedule: 58,333 shares on July 3, 2024, 58,333 shares on July 3, 2025 and 58,334 shares on July 3, 2026.
- [F2]On May 1, 2024, the reporting person was granted 175,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 58,333 shares on May 1, 2025, 58,333 shares on May 1, 2026 and 58,334 shares on May 1, 2027.
- [F3]Includes restricted stock units, which vest over various time periods. Due to administrative error, the above transactions are being reported late. The aggregate amount of securities beneficially owned includes the delinquent transactions plus all transactions reported in Form 4s filed after the date of the delinquent transactions.